Latest News and Press Releases

SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating novel therapeutics to target T-cell leukemia and lymphoma, today...

DUBLIN, Ireland, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Foundry Innovation & Research 1, Ltd. (FIRE1), today announced the close of a Series C financing totaling EUR 40 Million. The financing was led...

MENLO PARK, Calif. and BOSTON, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Lightstone Ventures (LSV), a leading global venture capital firm, today announced it has raised $250 million for Lightstone Ventures...

SINGAPORE, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Lightstone Ventures (LSV) today announced that MediSix Therapeutics Pte Ltd., an early-stage cell therapy company developing novel therapeutics to...

SINGAPORE--(Marketwired - Jan 9, 2017) -  The Foundry and Lightstone Ventures (LSV) today announced that they have joined forces to launch Foundry SING1, Inc. to identify and address unmet...

MENLO PARK, CA and BOSTON, MA--(Marketwired - Sep 7, 2016) - Lightstone Ventures (LSV) today announced the appointment of Susan M. Molineaux, Ph.D. as Scientific Advisor. In this role, she will...

DUBLIN, IRELAND--(Marketwired - Apr 12, 2016) - Foundry Innovation & Research 1, Ltd. ("FIRE1") today announced it has closed its Series B financing, appointed Conor Hanley as President and...

MENLO PARK, CA and BOSTON, MA--(Marketwired - Mar 2, 2016) - Lightstone Ventures (LSV) today announced the appointment of Stacy Enxing Seng as Venture Partner. In this role, she will assist the LSV...

MENLO PARK, CA and BOSTON, MA and SINGAPORE--(Marketwired - Feb 17, 2016) - Lightstone Ventures (LSV) today announced it has closed a US$50 million fund, Lightstone Singapore, L.P., focused on...

PALO ALTO, CA and BOSTON, MA--(Marketwired - Jun 11, 2014) - Lightstone Ventures (LSV) today announced the addition of Mark Deem and Hanson Gifford as its newest Venture Partners. Deem and...